Mary Spellman
2017
In 2017, Mary Spellman earned a total compensation of $626.4K as Chief Medical Officer at VYNE Therapeutics.
Compensation breakdown
| Bonus | $42,200 |
|---|---|
| Option Awards | $444,592 |
| Salary | $139,583 |
| Total | $626,375 |
Spellman received $444.6K in option awards, accounting for 71% of the total pay in 2017.
Spellman also received $42.2K in bonus and $139.6K in salary.
Rankings
In 2017, Mary Spellman's compensation ranked 11,039th out of 14,666 executives tracked by ExecPay. In other words, Spellman earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,039 out of 14,666 | 25th |
Division Manufacturing | 4,320 out of 5,772 | 25th |
Major group Chemicals And Allied Products | 1,564 out of 2,075 | 25th |
Industry group Drugs | 1,284 out of 1,731 | 26th |
Industry Pharmaceutical Preparations | 1,001 out of 1,333 | 25th |
Source: SEC filing on May 10, 2019.
Spellman's colleagues
We found two more compensation records of executives who worked with Mary Spellman at VYNE Therapeutics in 2017.